CYTOKINETICS, INCORPORATED Increase (Decrease) in Accounts Receivable
CYTOKINETICS, INCORPORATED (CYTK) reported Increase (Decrease) in Accounts Receivable of $6.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $17.61M, a 175.16% increase year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$10.94M.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $15.96M, a 2.74% decline year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$6.60M, a 2805.74% decline year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for fiscal 2025 was $1.11M, a 92.75% decline from fiscal 2024.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for fiscal 2024 was $15.37M, a 1252.73% increase from fiscal 2023.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for fiscal 2023 was $1.14M.
- CYTOKINETICS, INCORPORATED increase (decrease) in accounts receivable for fiscal 2022 was -$56.67M, a 219.56% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.67M 10-Q · filed 2026-08-06 | $22.62M derived: sum of 3 quarters · filed 2026-08-06 | $16.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$10.94M 10-Q · filed 2026-05-05 | $5.02M derived: sum of 2 quarters · filed 2026-05-05 | -$1.58M derived: sum of 3 quarters · filed 2026-05-05 | $4.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $15.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.35M derived: sum of 2 quarters · filed 2026-02-26 | $15.75M derived: sum of 3 quarters · filed 2026-08-06 | $1.11M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$204.00K derived: sum of 2 quarters · filed 2026-08-06 | -$14.84M 10-Q · filed 2025-11-05 | $1.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.24M 10-Q · filed 2026-08-06 | $8.17M derived: sum of 3 quarters · filed 2026-08-06 | $8.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$14.64M 10-Q · filed 2026-05-05 | $1.77M derived: sum of 2 quarters · filed 2026-05-05 | $2.01M derived: sum of 3 quarters · filed 2026-05-05 | $1.18M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $16.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.65M derived: sum of 2 quarters · filed 2026-02-26 | $15.82M derived: sum of 3 quarters · filed 2026-02-26 | $15.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | $244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$590.00K derived: sum of 2 quarters · filed 2025-11-05 | -$1.04M 10-Q · filed 2025-11-05 | -$2.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$834.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.28M 10-Q · filed 2025-08-07 | -$2.50M derived: sum of 3 quarters · filed 2026-02-26 | -$985.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$449.00K 10-Q · filed 2025-05-06 | -$1.67M derived: sum of 2 quarters · filed 2026-02-26 | -$151.00K derived: sum of 3 quarters · filed 2026-02-26 | -$172.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $298.00K derived: sum of 2 quarters · filed 2026-02-26 | $277.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.14M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.49M derived: sum of 2 quarters · filed 2024-11-07 | $2.35M 10-Q · filed 2024-11-07 | $205.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $838.00K 10-Q · filed 2024-08-09 | -$1.31M derived: sum of 3 quarters · filed 2025-02-27 | -$988.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $859.00K 10-Q · filed 2024-05-10 | -$1.29M derived: sum of 2 quarters · filed 2025-02-27 | -$967.00K derived: sum of 3 quarters · filed 2025-02-27 | -$5.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.83M derived: sum of 2 quarters · filed 2025-02-27 | -$5.91M derived: sum of 3 quarters · filed 2025-02-27 | -$56.67M 10-K · filed 2025-02-27 |
| 2022-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$3.76M derived: sum of 2 quarters · filed 2023-11-03 | -$54.52M 10-Q · filed 2023-11-03 | -$3.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$54.85M 10-Q · filed 2023-08-03 | -$3.67M derived: sum of 3 quarters · filed 2024-02-28 | -$5.73M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$50.76M 10-Q · filed 2023-05-05 | $412.00K derived: sum of 2 quarters · filed 2024-02-28 | -$1.65M derived: sum of 3 quarters · filed 2024-02-28 | -$3.46M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $51.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $49.12M derived: sum of 2 quarters · filed 2024-02-28 | $47.30M derived: sum of 3 quarters · filed 2024-02-28 | $47.40M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$3.87M derived: sum of 2 quarters · filed 2022-11-04 | -$3.78M 10-Q · filed 2022-11-04 | -$4.32M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$1.72M 10-Q · filed 2022-08-05 | -$2.26M derived: sum of 3 quarters · filed 2023-03-01 | $447.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $94.00K 10-Q · filed 2022-05-06 | -$451.00K derived: sum of 2 quarters · filed 2023-03-01 | $2.26M derived: sum of 3 quarters · filed 2023-03-01 | $1.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.17M derived: sum of 2 quarters · filed 2023-03-01 | $1.72M derived: sum of 3 quarters · filed 2023-03-01 | -$743.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.26M derived: sum of 2 quarters · filed 2021-11-05 | -$198.00K 10-Q · filed 2021-11-05 | -$1.61M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.91M 10-Q · filed 2021-08-06 | -$4.32M derived: sum of 3 quarters · filed 2022-02-25 | -$6.74M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$2.46M 10-Q · filed 2021-05-07 | -$3.87M derived: sum of 2 quarters · filed 2022-02-25 | -$6.29M derived: sum of 3 quarters · filed 2022-02-25 | -$1.46M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$3.83M derived: sum of 2 quarters · filed 2022-02-25 | $998.00K derived: sum of 3 quarters · filed 2022-02-25 | $2.93M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $2.41M derived: sum of 2 quarters · filed 2020-11-06 | $4.34M 10-Q · filed 2020-11-06 | -$2.58M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $6.76M 10-Q · filed 2020-08-07 | -$163.00K derived: sum of 3 quarters · filed 2021-02-26 | $8.76M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $1.93M 10-Q · filed 2020-05-08 | -$4.99M derived: sum of 2 quarters · filed 2021-02-26 | $3.93M derived: sum of 3 quarters · filed 2021-02-26 | $4.13M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.00M derived: sum of 2 quarters · filed 2021-02-26 | $2.19M derived: sum of 3 quarters · filed 2021-02-26 | $1.12M 10-K · filed 2021-02-26 |
| 2018-09-30 | $8.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $9.12M derived: sum of 2 quarters · filed 2019-11-01 | $8.04M 10-Q · filed 2019-11-01 | -$844.00K derived: sum of 4 quarters · filed 2019-11-01 |
| 2018-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$876.00K 10-Q · filed 2019-08-09 | -$9.76M derived: sum of 3 quarters · filed 2019-08-09 | $236.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$1.07M 10-Q · filed 2019-05-09 | -$9.96M derived: sum of 2 quarters · filed 2019-05-09 | $37.00K derived: sum of 3 quarters · filed 2019-05-09 | -$872.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.11M derived: sum of 2 quarters · filed 2019-03-07 | $203.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.09M 10-K · filed 2019-03-07 |
| 2017-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $9.09M derived: sum of 2 quarters · filed 2018-11-09 | $9.98M 10-Q · filed 2018-11-09 | -$57.00M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$24.00K 10-Q · filed 2018-08-07 | -$67.00M derived: sum of 3 quarters · filed 2018-08-07 | -$26.00K derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | $885.00K 10-Q · filed 2018-05-10 | -$66.09M derived: sum of 2 quarters · filed 2018-05-10 | $883.00K derived: sum of 3 quarters · filed 2018-05-10 | |
| 2016-12-31 | -$66.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | -$2.00K derived: sum of 2 quarters · filed 2018-03-05 | $12.00K 10-K · filed 2018-03-05 | |
| 2016-09-30 | $66.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $66.99M 10-Q · filed 2017-11-03 | ||
| 2016-06-30 | $14.00K 10-Q · filed 2017-08-04 | |||
| 2015-12-31 | -$46.63M 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |